Fundraising Fox
/Companies
Sign in

Ra Pharmaceuticals

Cambridge, US · Founded 1928 · Delaware corporation · 15,154 employees on LinkedIn · 4 known investors

Find your way into Ra Pharmaceuticals

Sign up to see every warm intro you have to Ra Pharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Ra Pharmaceuticals team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

UCB (UCB SA/NV) is a publicly listed biopharmaceutical company focused on research and development of medicines for defined patient populations. This page presents the company's corporate governance structure, including its Board of Directors and Executive Committee.

BiotechHealthtech

Founders & leadership

Ra Pharmaceuticals was founded in 1928 by Douglas A. Treco.

DADouglas A. Treco
Douglas A. TrecoFounderAdvisor at Lightstone Ventures
KBKerry Black
Kerry BlackVice President, Operations2010–2020
JT
Jean-Christophe TellierChief Executive Officer & Chairman of the Executive Committee
SD
Sandrine DufourExecutive Vice President, Chief Financial Officer
JL
Jean Luc FleurialExecutive Vice President, Chief Human Resources Officer
FD
Fiona du MonceauExecutive Vice President, Chief Commercial Officer
AH
Alistair HenryExecutive Vice President & Chief Scientific Officer
DJ
Denelle J. Waynick JohnsonExecutive Vice President & General Counsel
EC
Emmanuel CaeymaexExecutive Vice President, Patient Evidence
JM
Jacques MarbehantExecutive Vice President, Patient Supply

Board

EM
Edward MathersBoard director
RSRajeev Shah
Rajeev ShahBoard directorManaging Director at RA Capital

Investors · 4

New Enterprise Associates (NEA)listed by New Enterprise Associates (NEA)Menlo Park · $200K – $40M

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

RA Capitallisted by RA CapitalBoston

How we know: RA Capital's portfolio page · Not right? Tell us

MorgenthalerreportedPortola Valley

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$29.2M disclosed across 1 round · 2015

▶$29.2MraisedJul 2015 · 11 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas A. TrecoExecutive Officer, Director
  • Edward MathersDirector
  • Rajeev ShahDirector
  • Peter BisgaardDirector
  • Jason LettmanDirector
  • Kerry BlackExecutive Officer
  • Markus GoebelDirector
Offering amount
$58.5M
Amount sold
$29.2M
First sale
Jul 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Ra Pharmaceuticals went on to found or lead other companies.

Simon ReadChief Scientific Officer, Ra PharmaFounded Mariana Oncology +2Jason LettmannBoard MemberFounded Alx Oncology +1

Frequently asked questions

What does Ra Pharmaceuticals do?
UCB (UCB SA/NV) is a publicly listed biopharmaceutical company focused on research and development of medicines for defined patient populations. This page presents the company's corporate governance structure, including its Board of Directors and Executive Committee.
Who founded Ra Pharmaceuticals?
Ra Pharmaceuticals was founded by Douglas A. Treco in 1928.
Who are Ra Pharmaceuticals's investors?
Ra Pharmaceuticals's investors include Lightstone Ventures, New Enterprise Associates (NEA), RA Capital, Morgenthaler.
How much funding has Ra Pharmaceuticals raised?
Ra Pharmaceuticals has disclosed $29.2M raised across 1 round.
Where is Ra Pharmaceuticals headquartered?
Ra Pharmaceuticals is headquartered in Cambridge, US.